City

Basking Ridge (1)

Bethesda (1)

Boston (1)

Commack (1)

Evanston (1)

Harrison (1)

Middletown (1)

New York (1)

Uniondale (1)

Condition

Chronic Lymphocytic Leukemia (CLL) (2)

Small Lymphocytic Leukemia (SLL) (2)

Overall Status

Recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Memorial Sloan Kettering Cancer Center (1)

National Heart, Lung, and Blood Institute (NHLBI) (1)

Collaborator

BeiGene USA, Inc. (1)

Massachusetts General Hospital (1)

Roche-Genentech (1)

Intervention

duvelisib (1)

ibrutinib (1)

obinutuzumab (1)

venetoclax (1)

zanubrutinib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

small lymphocytic leukemia (sll)

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Leukemia (SLL) Trial in United States (Zanubrutinib, Obinutuzumab,

Recruiting

Chronic Lymphocytic Leukemia (CLL)
Small Lymphocytic Leukemia (SLL)

Zanubrutinib
+2 more

Evanston, Illinois
+7 more

Sep 9, 2022

Small Lymphocytic Leukemia (SLL), Chronic Lymphocytic Leukemia (CLL) Trial run by the NHLBI (Duvelisib, Ibrutinib)

Terminated

Has Results

Small Lymphocytic Leukemia (SLL)
Chronic Lymphocytic Leukemia (CLL)

Bethesda, Maryland

National Institutes of Health Clinical Center

Feb 15, 2022